Exact Mass: 426.2366

Exact Mass Matches: 426.2366

Found 500 metabolites which its exact mass value is equals to given mass value 426.2366, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Paliperidone

3-(2-(4-(6-Fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one

C23H27FN4O3 (426.2067)


Paliperidone is the primary active metabolite of the older antipsychotic risperidone. While its specific mechanism of action is unknown, it is believed that paliperidone and risperidone act via similar if not the same pathways. It has been proposed that the drugs therapeutic activity in schizophrenia is mediated through a combination of central dopamine Type 2 (D2) and serotonin Type 2 (5HT2A) receptor antagonism. Paliperidone is also active as an antagonist at alpha 1 and alpha 2 adrenergic receptors and H1 histaminergic receptors, which may explain some of the other effects of the drug. Paliperidone was approved by the FDA for treatment of schizophrenia on December 20, 2006. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia[1]. Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia[1].

   

Phospho-anandamide

Phospho-anandamide

C22H37NO5P- (426.2409)


   

Oxatomide

1-{3-[4-(diphenylmethyl)piperazin-1-yl]propyl}-2,3-dihydro-1H-1,3-benzodiazol-2-one

C27H30N4O (426.2419)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents Oxatomide is a first-generation piperazine H1-antihistamine. D018926 - Anti-Allergic Agents Oxatomide is a potent and orally active dual H1-histamine receptor and P2X7 receptor antagonist with antihistamine and anti-allergic activity. Oxatomide almost completely blocks the ATP-induced current in human P2X7 receptors (IC50 of 0.95 μM). Oxatomide inhibits ATP-induced Ca2+ influx with an IC50 value of 0.43 μM and also inhibits serotonin[1][2].

   

Prostaglandin PGE2 1-glyceryl ester

(2R)-2,3-Dihydroxypropyl (5Z)-7-[(1R,2R,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C23H38O7 (426.2617)


2-Arachidonoyl glycerol (2-AG) has been isolated from porcine brain,1 and has been characterized as the natural endocannabinoid ligand for the CB1 receptor.2 Incubation of 2-AG with COX-2 and specific prostaglandin H2 (PGH2) isomerases in cell cultures and isolated enzyme preparations results in prostaglandin glycerol ester formation.3 The biosynthesis of PGH, PGD, PGE, PGF, and TXA-2-glyceryl ester compounds have all been documented. The 2-glyceryl ester moiety equilibrates rapidly (within minutes) with the more stable 1-glyceryl ester, producing a 10:90 2:1-glyceryl ester mixture in typical aqueous media. While the stability and metabolism of these prostaglandin products has been investigated,4 little is known about their intrinsic biological activity. [HMDB] 2-Arachidonoyl glycerol (2-AG) has been isolated from porcine brain,1 and has been characterized as the natural endocannabinoid ligand for the CB1 receptor.2 Incubation of 2-AG with COX-2 and specific prostaglandin H2 (PGH2) isomerases in cell cultures and isolated enzyme preparations results in prostaglandin glycerol ester formation.3 The biosynthesis of PGH, PGD, PGE, PGF, and TXA-2-glyceryl ester compounds have all been documented. The 2-glyceryl ester moiety equilibrates rapidly (within minutes) with the more stable 1-glyceryl ester, producing a 10:90 2:1-glyceryl ester mixture in typical aqueous media. While the stability and metabolism of these prostaglandin products has been investigated,4 little is known about their intrinsic biological activity.

   

Cinnzeylanine

6,9,11,13,14-Pentahydroxy-3,7,10-trimethyl-11-(propan-2-yl)-15-oxapentacyclo[7.5.1.0¹,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecan-2-yl acetic acid

C22H34O8 (426.2254)


Constituent of Cinnamomum zeylanicum (cinnamon) and Cinnamomum cassia (Chinese cinnamon). Cinnzeylanine is found in chinese cinnamon, ceylon cinnamon, and herbs and spices. Cinnzeylanine is found in ceylan cinnamon. Cinnzeylanine is a constituent of Cinnamomum zeylanicum (cinnamon) and Cinnamomum cassia (Chinese cinnamon)

   

Prostaglandin D2-1-glyceryl ester

2,3-Dihydroxypropyl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid

C23H38O7 (426.2617)


2-Arachidonoyl glycerol (2-AG) has been isolated from porcine brain, and has been characterized as the natural endocannabinoid ligand for the CB1 receptor.1,2 Incubation of 2-AG with cyclooxygenase-2 (COX-2) and specific prostaglandin H2 (PGH2) isomerases in cell cultures and isolated enzyme preparations results in prostaglandin glycerol ester formation.3 The biosynthesis of PGH, PGD, PGE, PGF, and TXA-2-glyceryl ester compounds have all been documented. In RAW 264.7 cells, PGD2-2-glyceryl ester is the main COX metabolite.3 The 2-glyceryl ester moiety equilibrates rapidly (within minutes) with the more stable 1-glyceryl ester, producing a 10:90 mixture of the 1- and 2-glyceryl esters in typical aqueous media. While the stability and metabolism of these PG products have been investigated, little is known about their intrinsic biological activity. [HMDB] 2-Arachidonoyl glycerol (2-AG) has been isolated from porcine brain, and has been characterized as the natural endocannabinoid ligand for the CB1 receptor.1,2 Incubation of 2-AG with cyclooxygenase-2 (COX-2) and specific prostaglandin H2 (PGH2) isomerases in cell cultures and isolated enzyme preparations results in prostaglandin glycerol ester formation.3 The biosynthesis of PGH, PGD, PGE, PGF, and TXA-2-glyceryl ester compounds have all been documented. In RAW 264.7 cells, PGD2-2-glyceryl ester is the main COX metabolite.3 The 2-glyceryl ester moiety equilibrates rapidly (within minutes) with the more stable 1-glyceryl ester, producing a 10:90 mixture of the 1- and 2-glyceryl esters in typical aqueous media. While the stability and metabolism of these PG products have been investigated, little is known about their intrinsic biological activity.

   

Prostaglandin PGE2 glyceryl ester

1,3-Dihydroxypropan-2-yl (5Z)-7-[(1S,2S,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C23H38O7 (426.2617)


GE2 glycerol ester is a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. 2-Arachidonoyl glycerol (2-AG) has been isolated from porcine brain,1 and has been characterized as the natural endocannabinoid ligand for the CB1 receptor.2 Incubation of 2-AG with COX-2 and specific prostaglandin H2 (PGH2) isomerases in cell cultures and isolated enzyme preparations results in prostaglandin glycerol ester formation.3 The biosynthesis of PGH, PGD, PGE, PGF, and TXA-2-glyceryl ester compounds have all been documented. The 2-glyceryl ester moiety equilibrates rapidly (within minutes) with the more stable 1-glyceryl ester, producing a 10:90 2:1-glyceryl ester mixture in typical aqueous media. While the stability and metabolism of these prostaglandin products has been investigated,4 little is known about their intrinsic biological activity. Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. GE2 glycerol ester is a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons

   

Darifenacin

2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide

C28H30N2O2 (426.2307)


G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists Darifenacin (Enablex, Novartis) is a medication used to treat urinary incontinence. C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents Darifenacin(UK88525) is a selective M3 muscarinic receptor antagonist with pKi of 8.9. IC50 value: 8.9 (pKi) [1] Target: M3 receptor in vitro: Darifenacin exerts non-parallel rightward displacement of the agonist curve and also significant depression of the maximum response (+)-cis-Dioxolane produced concentration-dependent contraction of the isolated bladder of rat [1]. Darifenacin produces a concentration dependent increase in R123 (P-gp probe) accumulation in MDCK cells. Darifenacin stimulates ATPase activity in P-gp membrane in a clear concentration dependent response manner with an estimated ED50 value of 1.6 μM. Darifenacin (100 nM) shows a significantly greater permeability for darifenacin in the basolateral to apical direction resulting in an efflux ratio in BBMEC monolayers of approximately 2.6 [2]. in vivo: Darifenacin produces dose-dependent inhibition of amplitude of volume-induced bladder contractions(VIBCAMP), producing 35\% inhibition at dose of 283.3 nmol/kg and maximal inhibition of approximately 50–55\% [1]. Darifenacin (0.1 mg/kg i.v.) reduces bladder afferent activity in both Aδ and C fibers in female Sprague-Dawley rats, the decrease in afferent spikes in C fibers may be more pronounced than that in Aδ fibers [3].

   

Prostaglandin H2 2-glyceryl Ester

1,3-dihydroxypropan-2-yl (5Z)-7-[(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoate

C23H38O7 (426.2617)


Prostaglandin H2 2-glyceryl Ester is also known as 2-Glyceryl-prostaglandin H2. Prostaglandin H2 2-glyceryl Ester is considered to be practically insoluble (in water) and relatively neutral. Prostaglandin H2 2-glyceryl Ester is an eicosanoid lipid molecule

   

9-Hydroxy-risperidone

3-(2-(4-(6-Fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one

C23H27FN4O3 (426.2067)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   

Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-4-hydroxy-3-methoxy-alpha-(1-methylethyl)-

Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-4-hydroxy-3-methoxy-alpha-(1-methylethyl)-

C25H34N2O4 (426.2518)


   

(2s)-7-Amino-2-{[(R)-Hydroxy{(1r)-2-Methyl-1-[(3-Phenylpropanoyl)amino]propyl}phosphoryl]methyl}heptanoic Acid

(2s)-7-Amino-2-{[(R)-Hydroxy{(1r)-2-Methyl-1-[(3-Phenylpropanoyl)amino]propyl}phosphoryl]methyl}heptanoic Acid

C21H35N2O5P (426.2283)


   

Dual-release hydrocortisone

4-(2-tetradecanamidoethyl)phenyl sulfamate

C22H38N2O4S (426.2552)


   

MEK inhibitor

3-[({3-[(dimethylamino)methyl]phenyl}imino)(phenyl)methyl]-2-hydroxy-N-methyl-1H-indole-6-carboximidate

C26H26N4O2 (426.2056)


   

Perospirone

2-{4-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]butyl}-octahydro-1H-isoindole-1,3-dione

C23H30N4O2S (426.2089)


   

Pratosartan

2-propyl-3-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-3H,4H,5H,6H,7H,8H-cyclohepta[d]imidazol-4-one

C25H26N6O (426.2168)


   

Teneligliptin

1-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-4-[5-(1,3-thiazolidine-3-carbonyl)pyrrolidin-3-yl]piperazine

C22H30N6OS (426.2202)


   

MG(PGE2/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C23H38O7 (426.2617)


MG(PGE2/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(PGD2/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid

C23H38O7 (426.2617)


MG(PGD2/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/0:0)

(2S)-2,3-dihydroxypropyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C23H38O7 (426.2617)


MG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/PGE2/0:0)

1,3-dihydroxypropan-2-yl (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoate

C23H38O7 (426.2617)


MG(0:0/PGE2/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/PGD2/0:0)

1,3-dihydroxypropan-2-yl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoate

C23H38O7 (426.2617)


MG(0:0/PGD2/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

1,3-Dihydroxypropan-2-yl (5S,6S,7E,9E,11Z,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C23H38O7 (426.2617)


MG(0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

Cichorioside N

(1S,3aR,4R,5S,7S,7aR)-5-ethenyl-7-hydroxy-1,5-dimethyl-4-[(1E)-1-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl]-hexahydro-1H-inden-2-one

C22H34O8 (426.2254)


Cichorioside n is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Cichorioside n can be found in endive, which makes cichorioside n a potential biomarker for the consumption of this food product.

   

Vindolidin

Demethoxyvindoline

C24H30N2O5 (426.2155)


   

Parvifoline K

Parvifoline K

C22H34O8 (426.2254)


   

Methyl 17-(acetyloxy)-11-methoxyyohimban-16-carboxylate #

Methyl 17-(acetyloxy)-11-methoxyyohimban-16-carboxylate #

C24H30N2O5 (426.2155)


   

Sinulaflexiolide C

Sinulaflexiolide C

C22H34O8 (426.2254)


   

12-Methoxypleiocarpine

(-)-12-Methoxypleiocarpine

C24H30N2O5 (426.2155)


   

Pierisformosin B

Pierisformosin B

C23H38O7 (426.2617)


   

Junceellolide G

Junceellolide G

C22H34O8 (426.2254)


   
   

Dehydrogravicycle

Dehydrogravicycle

C26H34O5 (426.2406)


   
   

Patridoid II

Patridoid II

C22H34O8 (426.2254)


   

MCULE-4527677076

MCULE-4527677076

C28H30N2O2 (426.2307)


   

SM-9018 (free base)

SM-9018 (free base)

C23H30N4O2S (426.2089)


   
   
   

macrocalyxin G

macrocalyxin G

C22H34O8 (426.2254)


   

Patridoid I

Patridoid I

C22H34O8 (426.2254)


   

Deflectin 2b

Deflectin 2b

C26H34O5 (426.2406)


   

Obscurinervidine, 6,7-dihydro-

Obscurinervidine, 6,7-dihydro-

C24H30N2O5 (426.2155)


   

3-hydroxymethyl-aspidofractinine-1,3-dicarboxylic acid dimethyl ester|Pleiocarpolin

3-hydroxymethyl-aspidofractinine-1,3-dicarboxylic acid dimethyl ester|Pleiocarpolin

C24H30N2O5 (426.2155)


   

cladobotric acid D

cladobotric acid D

C26H34O5 (426.2406)


   

(rel-5S,6R,8R,9R,10S,13R,14S,15R,16S)-6-acetoxy-9,16;15,16-diepoxy-13,14-dihydroxy-15-methoxylabdane|viteagnusin G

(rel-5S,6R,8R,9R,10S,13R,14S,15R,16S)-6-acetoxy-9,16;15,16-diepoxy-13,14-dihydroxy-15-methoxylabdane|viteagnusin G

C23H38O7 (426.2617)


   

Macrocalyxin H

Macrocalyxin H

C22H34O8 (426.2254)


   

toonaciliatone A

toonaciliatone A

C26H34O5 (426.2406)


   
   

Strongylophorine 6|strongylophorine-6

Strongylophorine 6|strongylophorine-6

C26H34O5 (426.2406)


   

Triptogelin G-1

Triptogelin G-1

C26H34O5 (426.2406)


   

Hexyl 6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranoside|Hexyl-??-D-glucopyranosyl-(1鈥樏傗垎 6)-??-D-glucopyranoside

Hexyl 6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranoside|Hexyl-??-D-glucopyranosyl-(1鈥樏傗垎 6)-??-D-glucopyranoside

C18H34O11 (426.2101)


   

16-Epimer,O-Ac-10-Methoxyyohimbine

16-Epimer,O-Ac-10-Methoxyyohimbine

C24H30N2O5 (426.2155)


   

Parviflorene H

Parviflorene H

C30H34O2 (426.2559)


   

(19R)-1-acetyl-17,19-epoxy-10,11-dimethoxy-4-methyl-3,4-seco-cur-20-en-3-one|10,11-dimethoxy-strychnobrasiline|10,11-Dimethoxystrychnobrasilin|10,11-Dimethoxystrychnobrasiline

(19R)-1-acetyl-17,19-epoxy-10,11-dimethoxy-4-methyl-3,4-seco-cur-20-en-3-one|10,11-dimethoxy-strychnobrasiline|10,11-Dimethoxystrychnobrasilin|10,11-Dimethoxystrychnobrasiline

C24H30N2O5 (426.2155)


   

2,4-Diamino-2,4,6-trideoxygalactose-Benzyl glycoside, di-N-Ac, 3-benzyl

2,4-Diamino-2,4,6-trideoxygalactose-Benzyl glycoside, di-N-Ac, 3-benzyl

C24H30N2O5 (426.2155)


   

3-O-acetyl-4,5-O-di-(3methylvaleryl)-shikimic acid methyl ester|3-O-acetyl-4,5-O-di-<3methylvaleryl>-shikimic acid methyl ester

3-O-acetyl-4,5-O-di-(3methylvaleryl)-shikimic acid methyl ester|3-O-acetyl-4,5-O-di-<3methylvaleryl>-shikimic acid methyl ester

C22H34O8 (426.2254)


   
   

(1E,4S,5E,7R)-2-O-acetyl-7-O-beta-D-glucopyranosylgermacra-1(10),5-diene

(1E,4S,5E,7R)-2-O-acetyl-7-O-beta-D-glucopyranosylgermacra-1(10),5-diene

C23H38O7 (426.2617)


   

(4S,7R)-7-[(1E,3E,5E,7E)-8-[(2S,5R,6S)-5,6-dihydro-5-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione|wortmannilactone F

(4S,7R)-7-[(1E,3E,5E,7E)-8-[(2S,5R,6S)-5,6-dihydro-5-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione|wortmannilactone F

C26H34O5 (426.2406)


   

(5Z,8Z,11Z,13E,17Z)-2-eicosa-15(S)-hydroxy-5,8,11,13,17-pentaenoylphloroglucinol

(5Z,8Z,11Z,13E,17Z)-2-eicosa-15(S)-hydroxy-5,8,11,13,17-pentaenoylphloroglucinol

C26H34O5 (426.2406)


   

10beta-formamido-5-isocyanatokalihinol-A

10beta-formamido-5-isocyanatokalihinol-A

C22H35ClN2O4 (426.2285)


   

7alpha,21-dihydroxy-3-oxo-24,25,26,27-tetranorapotirucall-1,14,20(22)-trien-21,23-olide

7alpha,21-dihydroxy-3-oxo-24,25,26,27-tetranorapotirucall-1,14,20(22)-trien-21,23-olide

C26H34O5 (426.2406)


   

angustifolimine

angustifolimine

C25H34N2O4 (426.2518)


   
   

(1R,2S)-1-{[(1S,4aR,5R,8aS)-decahydro-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthalen-1-yl]methoxy}propane-1,2,3-tricarboxylic acid 2-methyl ester|cryptoporic acid N

(1R,2S)-1-{[(1S,4aR,5R,8aS)-decahydro-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthalen-1-yl]methoxy}propane-1,2,3-tricarboxylic acid 2-methyl ester|cryptoporic acid N

C22H34O8 (426.2254)


   

anthogorgiene G

anthogorgiene G

C30H34O2 (426.2559)


   

ethyl galbanate

ethyl galbanate

C26H34O5 (426.2406)


   
   

5-{(E)-2-[2-(1H-indol-5-yl)-1,4-bis(methoxymethyl)cyclohex-3-en-1-yl]ethenyl}-1H-indole|caulindole E

5-{(E)-2-[2-(1H-indol-5-yl)-1,4-bis(methoxymethyl)cyclohex-3-en-1-yl]ethenyl}-1H-indole|caulindole E

C28H30N2O2 (426.2307)


   

Hexyl beta-sophoroside|Hexyl-??-D-glucopyranosyl-(1鈥樏傗垎 2)-??-D-glucopyranoside

Hexyl beta-sophoroside|Hexyl-??-D-glucopyranosyl-(1鈥樏傗垎 2)-??-D-glucopyranoside

C18H34O11 (426.2101)


   

Echitovenaldine

Echitovenaldine

C24H30N2O5 (426.2155)


   

2-epi-botcinin A

2-epi-botcinin A

C22H34O8 (426.2254)


   

(4-methylpentyl-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|capsoside B

(4-methylpentyl-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|capsoside B

C18H34O11 (426.2101)


   

4-acetoxy-3-hydroxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester

4-acetoxy-3-hydroxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester

C24H30N2O5 (426.2155)


   

jaeschkeanadiol p-acetoxycoumarate

jaeschkeanadiol p-acetoxycoumarate

C26H34O5 (426.2406)


   

(1E,4S,5E,7R)-6O-acetyl-7-O-beta-D-glucopyranosylgermacra-1(10),5-diene

(1E,4S,5E,7R)-6O-acetyl-7-O-beta-D-glucopyranosylgermacra-1(10),5-diene

C23H38O7 (426.2617)


   

19,23-dihydroxyprotylonolide

19,23-dihydroxyprotylonolide

C23H38O7 (426.2617)


   

2,3-epoxy-5beta,6beta,9,10alpha,16alpha-pentahydroxy-7alpha-acetoxygrayanane|craiobiotoxin IV

2,3-epoxy-5beta,6beta,9,10alpha,16alpha-pentahydroxy-7alpha-acetoxygrayanane|craiobiotoxin IV

C22H34O8 (426.2254)


   

16beta-acetyloxy-14-hydroxy-bufa-5,20,22-trienolide

16beta-acetyloxy-14-hydroxy-bufa-5,20,22-trienolide

C26H34O5 (426.2406)


   

4,4-Oxybis(benzoic acid hexyl) ester

4,4-Oxybis(benzoic acid hexyl) ester

C26H34O5 (426.2406)


   

(5beta,9alpha,10alpha)-7-O-(3alpha-methoxy-8(12)-drimen-11-yl)-scopoletin|driportlandin

(5beta,9alpha,10alpha)-7-O-(3alpha-methoxy-8(12)-drimen-11-yl)-scopoletin|driportlandin

C26H34O5 (426.2406)


   

3-epi-dihydrocorymine 3-acetate

3-epi-dihydrocorymine 3-acetate

C24H30N2O5 (426.2155)


   

8beta-hydroxy-15-malonyloxy-ent-labdan-18-oic acid

8beta-hydroxy-15-malonyloxy-ent-labdan-18-oic acid

C23H38O7 (426.2617)


   

6-acetyl-8-t-cinnamylantakyatriol

6-acetyl-8-t-cinnamylantakyatriol

C26H34O5 (426.2406)


   

fekrynol acetate

fekrynol acetate

C26H34O5 (426.2406)


   

Ouabanginone

Ouabanginone

C26H34O5 (426.2406)


   

3-epi-dihydrocorymin 17-acetate

3-epi-dihydrocorymin 17-acetate

C24H30N2O5 (426.2155)


   

Paliperidone

Paliperidone (Invega)

C23H27FN4O3 (426.2067)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics CONFIDENCE standard compound; INTERNAL_ID 1568 Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia[1]. Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia[1].

   

Perospirone

perospirone

C23H30N4O2S (426.2089)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Perospirone (SM-9018 free base) is an orally active antagonist of 5-HT2A receptor (Ki=0.6 nM) and dopamine D2 receptor (Ki=1.4 nM), and also a partial agonist of 5-HT1A receptor (Ki=2.9 nM). Perospirone is an atypical antipsychotic agent and has the potential for schizophrenic disease research[1][2].

   

7-Hydroxyrisperidone

7-Hydroxyrisperidone

C23H27FN4O3 (426.2067)


   

Ala His Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

Ala His Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

Ala His Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Ala His Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Ala His Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C18H30N6O6 (426.2227)


   

Ala His Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Ala Ile His Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

Ala Ile Ser His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ala Leu His Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

Ala Leu Ser His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ala Ser His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Ala Ser His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Ala Ser Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ala Ser Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ala Thr His Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C18H30N6O6 (426.2227)


   

Ala Thr Val His

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ala Val His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Ala Val Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Asp Pro Pro Val

(3S)-3-amino-4-[(2S)-2-{[(2S)-2-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}pyrrolidin-1-yl]carbonyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C19H30N4O7 (426.2114)


   

Asp Pro Val Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C19H30N4O7 (426.2114)


   

Asp Val Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C19H30N4O7 (426.2114)


   

Gly His Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Gly His Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Gly His Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Gly His Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Gly Ile His Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Gly Ile Thr His

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Gly Leu His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Gly Leu Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Gly Thr His Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Gly Thr His Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Gly Thr Ile His

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Gly Thr Leu His

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

His Ala Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

His Ala Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

His Ala Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

His Ala Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

His Ala Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C18H30N6O6 (426.2227)


   

His Ala Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

His Gly Ile Thr

(2S,3R)-2-[(2S,3S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-methylpentanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

His Gly Leu Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-4-methylpentanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

His Gly Thr Ile

(2S,3S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-hydroxybutanamido]-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

His Gly Thr Leu

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-hydroxybutanamido]-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

His Ile Ala Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

His Ile Gly Thr

(2S,3R)-2-{2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]acetamido}-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

His Ile Ser Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-hydroxypropanamido]propanoic acid

C18H30N6O6 (426.2227)


   

His Ile Thr Gly

2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-hydroxybutanamido]acetic acid

C18H30N6O6 (426.2227)


   

His Leu Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

His Leu Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]acetamido}-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

His Leu Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-hydroxypropanamido]propanoic acid

C18H30N6O6 (426.2227)


   

His Leu Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-hydroxybutanamido]acetic acid

C18H30N6O6 (426.2227)


   

His Ser Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]propanamido]-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

His Ser Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]propanamido]-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

His Ser Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-methylpentanamido]propanoic acid

C18H30N6O6 (426.2227)


   

His Ser Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-4-methylpentanamido]propanoic acid

C18H30N6O6 (426.2227)


   

His Thr Ala Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]propanamido]-3-methylbutanoic acid

C18H30N6O6 (426.2227)


   

His Thr Gly Ile

(2S,3S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]acetamido}-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

His Thr Gly Leu

(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]acetamido}-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

His Thr Ile Gly

2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-methylpentanamido]acetic acid

C18H30N6O6 (426.2227)


   

His Thr Leu Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-4-methylpentanamido]acetic acid

C18H30N6O6 (426.2227)


   

His Thr Val Ala

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-methylbutanamido]propanoic acid

C18H30N6O6 (426.2227)


   

His Val Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]propanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

His Val Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-hydroxybutanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Ile Ala His Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

Ile Ala Ser His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ile Gly His Thr

(2S,3R)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Ile Gly Thr His

(2S)-2-[(2S,3R)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ile His Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

Ile His Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Ile His Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Ile His Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]acetic acid

C18H30N6O6 (426.2227)


   

Ile Pro Pro Thr

(2S,3R)-2-{[(2S)-1-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C20H34N4O6 (426.2478)


   

Ile Pro Thr Pro

(2S)-1-[(2S,3R)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Ile Ser Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ile Ser His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Ile Thr Gly His

(2S)-2-{2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ile Thr His Gly

2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C18H30N6O6 (426.2227)


   

Ile Thr Pro Pro

(2S)-1-{[(2S)-1-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Leu Ala His Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

Leu Ala Ser His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Leu Gly His Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Leu Gly Thr His

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Leu His Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-hydroxypropanoic acid

C18H30N6O6 (426.2227)


   

Leu His Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Leu His Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Leu His Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]acetic acid

C18H30N6O6 (426.2227)


   

Leu Pro Pro Thr

(2S,3R)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C20H34N4O6 (426.2478)


   

Leu Pro Thr Pro

(2S)-1-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Leu Ser Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Leu Ser His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Leu Thr Gly His

(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Leu Thr His Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C18H30N6O6 (426.2227)


   

Leu Thr Pro Pro

(2S)-1-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Pro Asp Pro Val

(2S)-2-{[(2S)-1-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C19H30N4O7 (426.2114)


   

Pro Asp Val Pro

(2S)-1-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C19H30N4O7 (426.2114)


   

Pro Ile Pro Thr

(2S,3R)-3-hydroxy-2-{[(2S)-1-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}butanoic acid

C20H34N4O6 (426.2478)


   

Pro Ile Thr Pro

(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanoyl]pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Pro Leu Pro Thr

(2S,3R)-3-hydroxy-2-{[(2S)-1-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}butanoic acid

C20H34N4O6 (426.2478)


   

Pro Leu Thr Pro

(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanoyl]pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Pro Pro Asp Val

(2S)-2-[(2S)-3-carboxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]-3-methylbutanoic acid

C19H30N4O7 (426.2114)


   

Pro Pro Ile Thr

(2S,3R)-3-hydroxy-2-[(2S,3S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]butanoic acid

C20H34N4O6 (426.2478)


   

Pro Pro Leu Thr

(2S,3R)-3-hydroxy-2-[(2S)-4-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]butanoic acid

C20H34N4O6 (426.2478)


   

Pro Pro Thr Ile

(2S,3S)-2-[(2S,3R)-3-hydroxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]-3-methylpentanoic acid

C20H34N4O6 (426.2478)


   

Pro Pro Thr Leu

(2S)-2-[(2S,3R)-3-hydroxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]-4-methylpentanoic acid

C20H34N4O6 (426.2478)


   

Pro Pro Val Asp

(2S)-2-[(2S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]butanedioic acid

C19H30N4O7 (426.2114)


   

Pro Thr Ile Pro

(2S)-1-[(2S,3S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Pro Thr Leu Pro

(2S)-1-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Pro Thr Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H34N4O6 (426.2478)


   

Pro Thr Pro Leu

(2S)-2-{[(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H34N4O6 (426.2478)


   

Pro Val Asp Pro

(2S)-1-[(2S)-3-carboxy-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H30N4O7 (426.2114)


   

Pro Val Pro Asp

(2S)-2-{[(2S)-1-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C19H30N4O7 (426.2114)


   

Ser Ala His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Ser Ala His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Ser Ala Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ser Ala Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ser His Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Ser His Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Ser His Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Ser His Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Ser Ile Ala His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ser Ile His Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Ser Leu Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Ser Leu His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Thr Ala His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C18H30N6O6 (426.2227)


   

Thr Ala Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Thr Gly His Ile

(2S,3S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Thr Gly His Leu

(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Thr Gly Ile His

(2S)-2-[(2S,3S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Thr Gly Leu His

(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Thr His Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylbutanoic acid

C18H30N6O6 (426.2227)


   

Thr His Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Thr His Gly Leu

(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-4-methylpentanoic acid

C18H30N6O6 (426.2227)


   

Thr His Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]acetic acid

C18H30N6O6 (426.2227)


   

Thr His Leu Gly

2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]acetic acid

C18H30N6O6 (426.2227)


   

Thr His Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Thr Ile Gly His

(2S)-2-{2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Thr Ile His Gly

2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C18H30N6O6 (426.2227)


   

Thr Ile Pro Pro

(2S)-1-{[(2S)-1-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Thr Leu Gly His

(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Thr Leu His Gly

2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C18H30N6O6 (426.2227)


   

Thr Leu Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Thr Pro Ile Pro

(2S)-1-[(2S,3S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Thr Pro Leu Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H34N4O6 (426.2478)


   

Thr Pro Pro Ile

(2S,3S)-2-{[(2S)-1-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H34N4O6 (426.2478)


   

Thr Pro Pro Leu

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H34N4O6 (426.2478)


   

Thr Val Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Thr Val His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Val Ala His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Val Ala Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Val Asp Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C19H30N4O7 (426.2114)


   

Val His Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-hydroxybutanoic acid

C18H30N6O6 (426.2227)


   

Val His Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]propanoic acid

C18H30N6O6 (426.2227)


   

Val Pro Asp Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C19H30N4O7 (426.2114)


   

Val Pro Pro Asp

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanedioic acid

C19H30N4O7 (426.2114)


   

Val Thr Ala His

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H30N6O6 (426.2227)


   

Val Thr His Ala

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C18H30N6O6 (426.2227)


   

N,O-Didesmethylverapamil

N,O-Didesmethylverapamil

C25H34N2O4 (426.2518)


   

2-glyceryl-PGD2

9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid 2-glyceryl ester

C23H38O7 (426.2617)


   

PGD2-G

9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid 1(3)-glyceryl ester

C23H38O7 (426.2617)


   

2-glyceryl-PGE2

9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid 2-glyceryl ester

C23H38O7 (426.2617)


   

PGE2-G

9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid 1(3)-glyceryl ester

C23H38O7 (426.2617)


   

2-glyceryl-PGH2

9S,11R-epidioxy-15S-hydroxy-5Z,13E-prostadienoic acid 2-glyceryl ester

C23H38O7 (426.2617)


   

PGH2-G

9S,11R-epidioxy-15S-hydroxy-5Z,13E-prostadienoic acid 1(3)-glyceryl ester

C23H38O7 (426.2617)


   

DIHYDRO-7-DESACETYLDEOXYGEDUNIN

DIHYDRO-7-DESACETYLDEOXYGEDUNIN

C26H34O5 (426.2406)


   

Methylcarbamyl PAF C-8

1-O-octyl-2-O-(N-methylcarbamoyl)-sn-glyceryl-3-phosphorylcholine

C18H39N2O7P (426.2495)


   

1-PGE(,2)-g

(2R)-2,3-dihydroxypropyl (5Z)-7-[(1R,2R,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoate

C23H38O7 (426.2617)


   

PGD2-1-Glyceryl ester

2,3-dihydroxypropyl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoate

C23H38O7 (426.2617)


   

Darifenacin

2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide

C28H30N2O2 (426.2307)


G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents Darifenacin(UK88525) is a selective M3 muscarinic receptor antagonist with pKi of 8.9. IC50 value: 8.9 (pKi) [1] Target: M3 receptor in vitro: Darifenacin exerts non-parallel rightward displacement of the agonist curve and also significant depression of the maximum response (+)-cis-Dioxolane produced concentration-dependent contraction of the isolated bladder of rat [1]. Darifenacin produces a concentration dependent increase in R123 (P-gp probe) accumulation in MDCK cells. Darifenacin stimulates ATPase activity in P-gp membrane in a clear concentration dependent response manner with an estimated ED50 value of 1.6 μM. Darifenacin (100 nM) shows a significantly greater permeability for darifenacin in the basolateral to apical direction resulting in an efflux ratio in BBMEC monolayers of approximately 2.6 [2]. in vivo: Darifenacin produces dose-dependent inhibition of amplitude of volume-induced bladder contractions(VIBCAMP), producing 35\% inhibition at dose of 283.3 nmol/kg and maximal inhibition of approximately 50–55\% [1]. Darifenacin (0.1 mg/kg i.v.) reduces bladder afferent activity in both Aδ and C fibers in female Sprague-Dawley rats, the decrease in afferent spikes in C fibers may be more pronounced than that in Aδ fibers [3].

   

Cinnzeylanine

6,9,11,13,14-pentahydroxy-3,7,10-trimethyl-11-(propan-2-yl)-15-oxapentacyclo[7.5.1.0^{1,6}.0^{7,13}.0^{10,14}]pentadecan-2-yl acetate

C22H34O8 (426.2254)


   

FA 23:4;O5

9S,11R-epidioxy-15S-hydroxy-5Z,13E-prostadienoic acid 2-glyceryl ester

C23H38O7 (426.2617)


   

2-eicosa-15S-hydroxy-5Z,8Z,11Z,13E,17Z-pentaenoylphloroglucinol

15S-Hydroxy-1-(2,4,6-trihydroxyphenyl)-5Z,8Z,11Z,13E,17Z-eicosapentaen-1-one

C26H34O5 (426.2406)


   

2-benzofuran-1,3-dione,2-[2-(2-hydroxyethoxy)ethoxy]ethanol,2,2,4-trimethylhexane

2-benzofuran-1,3-dione,2-[2-(2-hydroxyethoxy)ethoxy]ethanol,2,2,4-trimethylhexane

C23H38O7 (426.2617)


   

10,15-Dihydro-5,5,10,10,15,15-hexamethyl-5H-tribenzo[a,f,k]trindene

10,15-Dihydro-5,5,10,10,15,15-hexamethyl-5H-tribenzo[a,f,k]trindene

C33H30 (426.2347)


   

Nickel,bis(2,2,6,6-tetramethyl-3,5-heptanedionato-kO3,kO5)-, (SP-4-1)-

Nickel,bis(2,2,6,6-tetramethyl-3,5-heptanedionato-kO3,kO5)-, (SP-4-1)-

C22H40NiO4 (426.228)


   
   

H-D-Val-Leu-Lys-chloromethylketone trifluoroacetate salt

H-D-Val-Leu-Lys-chloromethylketone trifluoroacetate salt

C18H36Cl2N4O3 (426.2164)


   

Mehtyl 6-[3-(1-adamanty)-4-methoxy phenyl]-2-naphthoate

Mehtyl 6-[3-(1-adamanty)-4-methoxy phenyl]-2-naphthoate

C29H30O3 (426.2195)


   

BIS(N,N,NN-TETRAMETHYL-D-TARTRAMIDEGLYCOLATO)DIBORON

BIS(N,N,NN-TETRAMETHYL-D-TARTRAMIDEGLYCOLATO)DIBORON

C16H28B2N4O8 (426.2093)


   

4(or 5)-(di-1H-indol-1-ylmethyl)-α,α-dimethylcyclohexenebutan-1-ol

4(or 5)-(di-1H-indol-1-ylmethyl)-α,α-dimethylcyclohexenebutan-1-ol

C29H34N2O (426.2671)


   

d,l-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol hcl

d,l-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol hcl

C23H39ClN2O3 (426.2649)


   

Teneligliptin

Teneligliptin

C22H30N6OS (426.2202)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

(3S,4S)-TERT-BUTYL 3-(BENZYL((BENZYLOXY)CARBONYL)AMINO)-4-HYDROXYPYRROLIDINE-1-CARBOXYLATE

(3S,4S)-TERT-BUTYL 3-(BENZYL((BENZYLOXY)CARBONYL)AMINO)-4-HYDROXYPYRROLIDINE-1-CARBOXYLATE

C24H30N2O5 (426.2155)


   

1,3-diisocyanato-2-methylbenzene,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexane-1,6-diol

1,3-diisocyanato-2-methylbenzene,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexane-1,6-diol

C21H34N2O7 (426.2366)


   

DU-14

Sulfamic acid, 4-(2-((1-oxotetradecyl)amino)ethyl)phenyl ester

C22H38N2O4S (426.2552)


   

Teneligliptin (2R,4R)-Isomer

[4-[4-(5-Methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone

C22H30N6OS (426.2202)


   

[(2S,4R)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinylmethanone

[(2S,4R)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinylmethanone

C22H30N6OS (426.2202)


   

13-cis-N-2-Quinolinyl-retinamide

13-cis-N-2-Quinolinyl-retinamide

C29H34N2O (426.2671)


   

Risperidone N-oxide

Risperidone N-oxide

C23H27FN4O3 (426.2067)


   

Paliperidone Impurity 1

Paliperidone Impurity 1

C23H27FN4O3 (426.2067)


   

N-Carbobenzoxy-L-leucyl-L-alanine benzyl ester

N-Carbobenzoxy-L-leucyl-L-alanine benzyl ester

C24H30N2O5 (426.2155)


   

n-3-(triethoxysilylpropyl)-n-3-(trimethoxysilyl-propyl)urea

n-3-(triethoxysilylpropyl)-n-3-(trimethoxysilyl-propyl)urea

C16H38N2O7Si2 (426.2217)


   

hexyl-b-d-maltoside

hexyl-b-d-maltoside

C18H34O11 (426.2101)


   

quinine valerate

quinine valerate

C25H34N2O4 (426.2518)


   

BIS(N,N,NN-TETRAMETHYL-L-TARTRAMIDEGLYCOLATO)DIBORON

BIS(N,N,NN-TETRAMETHYL-L-TARTRAMIDEGLYCOLATO)DIBORON

C16H28B2N4O8 (426.2093)


   

Pratosartan

Pratosartan

C25H26N6O (426.2168)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist

   
   
   

oxatomide

oxatomide

C27H30N4O (426.2419)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D018926 - Anti-Allergic Agents Oxatomide is a potent and orally active dual H1-histamine receptor and P2X7 receptor antagonist with antihistamine and anti-allergic activity. Oxatomide almost completely blocks the ATP-induced current in human P2X7 receptors (IC50 of 0.95 μM). Oxatomide inhibits ATP-induced Ca2+ influx with an IC50 value of 0.43 μM and also inhibits serotonin[1][2].

   

Prostaglandin D2-1-glyceryl ester

Prostaglandin D2-1-glyceryl ester

C23H38O7 (426.2617)


   

prostaglandin E2 1-glyceryl ester

prostaglandin E2 1-glyceryl ester

C23H38O7 (426.2617)


A 1-monoglyceride resulting from the condensation of the carboxy group of prostaglandin E2 with the 1-hydroxy group of glycerol.

   

methyl (1R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

methyl (1R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

C24H30N2O5 (426.2155)


   

MG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/0:0)

MG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/0:0)

C23H38O7 (426.2617)


   

MG(0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

MG(0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C23H38O7 (426.2617)


   

(3S,3aR,4S,6S,7R,7aR)-6-ethenyl-4-hydroxy-3,6-dimethyl-7-[(E)-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyprop-1-en-2-yl]-3,3a,4,5,7,7a-hexahydro-1H-inden-2-one

(3S,3aR,4S,6S,7R,7aR)-6-ethenyl-4-hydroxy-3,6-dimethyl-7-[(E)-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyprop-1-en-2-yl]-3,3a,4,5,7,7a-hexahydro-1H-inden-2-one

C22H34O8 (426.2254)


   

Asp-Val-Pro-Pro

Asp-Val-Pro-Pro

C19H30N4O7 (426.2114)


A tetrapeptide composed of L-aspartic acid, L-valine and two L-proline units joined in sequence by peptide linkages.

   

N-[1-[(cyclohexylamino)-oxomethyl]cyclohexyl]-N-(thiophen-2-ylmethyl)-2-pyrazinecarboxamide

N-[1-[(cyclohexylamino)-oxomethyl]cyclohexyl]-N-(thiophen-2-ylmethyl)-2-pyrazinecarboxamide

C23H30N4O2S (426.2089)


   

Isoadenolin D, (rel)-

Isoadenolin D, (rel)-

C22H34O8 (426.2254)


A natural product found in Isodon adenolomus.

   

N-[3-(diethylamino)propyl]-4-[(2-methyl-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)hydrazo]-4-oxobutanamide

N-[3-(diethylamino)propyl]-4-[(2-methyl-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)hydrazo]-4-oxobutanamide

C21H30N8O2 (426.2492)


   

1-[[4-Anilino-6-(1-piperidinyl)-1,3,5-triazin-2-yl]amino]-3-cyclohexylthiourea

1-[[4-Anilino-6-(1-piperidinyl)-1,3,5-triazin-2-yl]amino]-3-cyclohexylthiourea

C21H30N8S (426.2314)


   

1-[3-(dimethylamino)propyl]-3-(4-fluorophenyl)-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]urea

1-[3-(dimethylamino)propyl]-3-(4-fluorophenyl)-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]urea

C23H27FN4O3 (426.2067)


   

N-[2-(cyclohexylamino)-2-oxoethyl]-N-(5-methyl-3-isoxazolyl)-N-phenylpentanediamide

N-[2-(cyclohexylamino)-2-oxoethyl]-N-(5-methyl-3-isoxazolyl)-N-phenylpentanediamide

C23H30N4O4 (426.2267)


   

8-methyl-4-oxo-N-[3-(4-propyl-1-piperazinyl)propyl]-5H-thieno[3,2-c]quinoline-2-carboxamide

8-methyl-4-oxo-N-[3-(4-propyl-1-piperazinyl)propyl]-5H-thieno[3,2-c]quinoline-2-carboxamide

C23H30N4O2S (426.2089)


   

(3aS,5S,9aS)-2-[(2-methylphenyl)methyl]-5-(1-methyl-3-phenyl-4-pyrazolyl)-3a,4,5,7,8,9-hexahydro-3H-pyrrolo[3,4-h]pyrrolizin-1-one

(3aS,5S,9aS)-2-[(2-methylphenyl)methyl]-5-(1-methyl-3-phenyl-4-pyrazolyl)-3a,4,5,7,8,9-hexahydro-3H-pyrrolo[3,4-h]pyrrolizin-1-one

C27H30N4O (426.2419)


   

(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C24H34N4O3 (426.2631)


   

(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C24H34N4O3 (426.2631)


   

2-[(1S,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(1S,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C24H30N2O5 (426.2155)


   

3-methyl-2-[[2-(methylamino)-1-oxopropyl]amino]-N-[3-methyl-1-(1-naphthalenylamino)-1-oxobutan-2-yl]butanamide

3-methyl-2-[[2-(methylamino)-1-oxopropyl]amino]-N-[3-methyl-1-(1-naphthalenylamino)-1-oxobutan-2-yl]butanamide

C24H34N4O3 (426.2631)


   

1,2-Dipentanoyl-sn-glycero-3-phosphocholine

1,2-Dipentanoyl-sn-glycero-3-phosphocholine

C18H37NO8P+ (426.2257)


   

(4R)-2-[4-(3-hydroxypropoxy)phenyl]-N-(3-methoxypropyl)-4-(phenylmethyl)-5H-oxazole-4-carboxamide

(4R)-2-[4-(3-hydroxypropoxy)phenyl]-N-(3-methoxypropyl)-4-(phenylmethyl)-5H-oxazole-4-carboxamide

C24H30N2O5 (426.2155)


   

3-[3-[4-[Hydroxy(diphenyl)methyl]-1-piperidinyl]propoxy]benzonitrile

3-[3-[4-[Hydroxy(diphenyl)methyl]-1-piperidinyl]propoxy]benzonitrile

C28H30N2O2 (426.2307)


   

(1S,5R)-3-[(3,5-dimethoxyphenyl)methyl]-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane

(1S,5R)-3-[(3,5-dimethoxyphenyl)methyl]-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane

C28H30N2O2 (426.2307)


   

2-[(1S,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(1S,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C24H30N2O5 (426.2155)


   

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C23H30N4O4 (426.2267)


   

(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C24H34N4O3 (426.2631)


   

(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C24H34N4O3 (426.2631)


   

1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

C23H30N4O4 (426.2267)


   

1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

C23H30N4O4 (426.2267)


   

(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C24H34N4O3 (426.2631)


   

(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C24H34N4O3 (426.2631)


   

1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

C23H30N4O4 (426.2267)


   

2-[(1R,3R,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(1R,3R,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C24H30N2O5 (426.2155)


   

2-[(1R,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide

2-[(1R,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide

C24H30N2O5 (426.2155)


   

(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C24H34N4O3 (426.2631)


   

(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C24H34N4O3 (426.2631)


   

(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C24H34N4O3 (426.2631)


   

1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

C23H30N4O4 (426.2267)


   

1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

C23H30N4O4 (426.2267)


   

1-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

1-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

C23H30N4O4 (426.2267)


   

1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea

C23H30N4O4 (426.2267)


   

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C23H30N4O4 (426.2267)


   

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C23H30N4O4 (426.2267)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C23H30N4O4 (426.2267)


   

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C23H30N4O4 (426.2267)


   

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C23H30N4O4 (426.2267)


   

(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C24H34N4O3 (426.2631)


   

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C23H30N4O4 (426.2267)


   

2-[(1R,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(1R,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C24H30N2O5 (426.2155)


   

2-[(1S,3S,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(1S,3S,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C24H30N2O5 (426.2155)


   

2-[(1R,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(1R,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C24H30N2O5 (426.2155)


   

2-[(1S,3R,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide

2-[(1S,3R,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide

C24H30N2O5 (426.2155)


   

2-[(1S,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide

2-[(1S,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide

C24H30N2O5 (426.2155)


   

1,3-dihydroxypropan-2-yl (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate

1,3-dihydroxypropan-2-yl (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate

C23H38O7 (426.2617)


   

1-(4-Azidobenzyl)-4-[2-(diphenylmethoxy)ethyl]piperidine

1-(4-Azidobenzyl)-4-[2-(diphenylmethoxy)ethyl]piperidine

C27H30N4O (426.2419)


   

2-[hydroxy-[(2R)-2-hydroxy-3-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-2-hydroxy-3-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C19H41NO7P+ (426.2621)


   

2-[(3S)-3-benzylpiperazin-1-yl]-4-(4-imidazol-1-ylphenoxy)-5-methylpyrimidine

2-[(3S)-3-benzylpiperazin-1-yl]-4-(4-imidazol-1-ylphenoxy)-5-methylpyrimidine

C25H26N6O (426.2168)


   

2,3-dihydroxypropyl [2-hydroxy-3-[(Z)-tridec-9-enoxy]propyl] hydrogen phosphate

2,3-dihydroxypropyl [2-hydroxy-3-[(Z)-tridec-9-enoxy]propyl] hydrogen phosphate

C19H39O8P (426.2382)


   

2-[2,3-Di(pentanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[2,3-Di(pentanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium

C18H37NO8P+ (426.2257)


   

2(Isobutylmethyl(2-naphthylsilyl))-1-(trimethylsilyl)naphthalene

2(Isobutylmethyl(2-naphthylsilyl))-1-(trimethylsilyl)naphthalene

C28H34Si2 (426.2199)


   

2-[Hydroxy-(2-hydroxy-3-undecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(2-hydroxy-3-undecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C19H41NO7P+ (426.2621)


   

2-[(3-Acetyloxy-2-octanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Acetyloxy-2-octanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C18H37NO8P+ (426.2257)


   

2-[(3-Butanoyloxy-2-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Butanoyloxy-2-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C18H37NO8P+ (426.2257)


   

2-[(2-Heptanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Heptanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C18H37NO8P+ (426.2257)


   

2-[Hydroxy-(3-octoxy-2-propanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(3-octoxy-2-propanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C19H41NO7P+ (426.2621)


   

2-[(2-Acetyloxy-3-nonoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Acetyloxy-3-nonoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C19H41NO7P+ (426.2621)


   

9-Hydroxy-risperidone

9-Hydroxy-risperidone

C23H27FN4O3 (426.2067)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   

2-glyceryl-Prostaglandin H2

2-glyceryl-Prostaglandin H2

C23H38O7 (426.2617)


   

2-glyceryl-Prostaglandin D2

2-glyceryl-Prostaglandin D2

C23H38O7 (426.2617)


   

2-glyceryl-Prostaglandin E2

2-glyceryl-Prostaglandin E2

C23H38O7 (426.2617)


   

Prostaglandin PGE2 glyceryl ester

Prostaglandin PGE2 glyceryl ester

C23H38O7 (426.2617)


   

Prostaglandin PGE2 1-glyceryl ester

Prostaglandin PGE2 1-glyceryl ester

C23H38O7 (426.2617)


   

prostaglandin I2 2-glyceryl ester

prostaglandin I2 2-glyceryl ester

C23H38O7 (426.2617)


A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin I2 with the 2-hydroxy group of glycerol.

   

Prostaglandin H2 2-glyceryl Ester

Prostaglandin H2 2-glyceryl Ester

C23H38O7 (426.2617)


A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin H2 with the 2-hydroxy group of glycerol.

   

prostaglandin D2 1-glyceryl ester

prostaglandin D2 1-glyceryl ester

C23H38O7 (426.2617)


A 1-monoglyceride resulting from the condensation of the carboxy group of prostaglandin D2 with the 1-hydroxy group of glycerol.

   

prostaglandin D2 2-glyceryl ester

prostaglandin D2 2-glyceryl ester

C23H38O7 (426.2617)


A 2-monoglyceride resulting from the condensation of the carboxy group of prostaglandin D2 with the 2-hydroxy group of glycerol.

   

prostaglandin E2 2-glyceryl ester

prostaglandin E2 2-glyceryl ester

C23H38O7 (426.2617)


A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin E2 with the 2-hydroxy group of glycerol.

   

1-Glyceryl-PGE2

1-Glyceryl-PGE2

C23H38O7 (426.2617)


   

Glyceryl-PGE2

Glyceryl-PGE2

C23H38O7 (426.2617)


   
   

ST 23:1;O2;S

ST 23:1;O2;S

C23H38O5S (426.244)


   
   
   
   

(±)-Darifenacin

(±)-Darifenacin

C28H30N2O2 (426.2307)


(±)-Darifenacin is the racemate of Darifenacin. Darifenacin is a selective M3 muscarinic receptor antagonist[1].

   

SB269652

SB269652

C27H30N4O (426.2419)


SB269652 is the first drug-like allosteric modulator of the dopamine D2 receptor (D2R); a new chemical probe that can differentiate D2R monomers from dimers or oligomers depending on the observed pharmacology. IC50 value: 0.2/0.5 nM [1] Target: D3 receptor antagonist SB269,652 potently (low nanomolar range) abolished specific binding of [(3)H]nemanopride and [(3)H]spiperone to Chinese hamster ovary-transfected D(3) receptors when radioligands were used at 0.2 and 0.5 nM, respectively. However, even at high concentrations (5 μM), SB269,652 only submaximally inhibited the specific binding of these radioligands when they were employed at 10-fold higher concentrations. By analogy, although SB269,652 potently blocked D(3) receptor-mediated activation of Gα(i3) and phosphorylation of extracellular-signal-regulated kinase (ERK)1/2, when concentrations of dopamine were increased by 10-fold, from 1 μM to 10 μM, SB269,652 only submaximally inhibited dopamine-induced stimulation of Gα(i3) [1].

   

(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(1r,2e,4s,7e)-4-isopropyl-1,7-dimethylcyclodeca-2,7-dien-1-yl]oxy}oxan-3-yl acetate

(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(1r,2e,4s,7e)-4-isopropyl-1,7-dimethylcyclodeca-2,7-dien-1-yl]oxy}oxan-3-yl acetate

C23H38O7 (426.2617)


   

(1s,2r,3r,4r,7s,8z,12s,13s,14s,17s)-3,12,14,17-tetrahydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate

(1s,2r,3r,4r,7s,8z,12s,13s,14s,17s)-3,12,14,17-tetrahydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate

C22H34O8 (426.2254)


   

methyl (1s,9s,10r,12s,13e,18r)-18-[(acetyloxy)methyl]-13-ethylidene-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

methyl (1s,9s,10r,12s,13e,18r)-18-[(acetyloxy)methyl]-13-ethylidene-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C24H30N2O5 (426.2155)


   

(1s,2r,5s,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl (2e)-3-phenylprop-2-enoate

(1s,2r,5s,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl (2e)-3-phenylprop-2-enoate

C26H34O5 (426.2406)


   

(7r)-7-[(1e,3e,5e,7e)-8-[(2s,3r,6s)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(7r)-7-[(1e,3e,5e,7e)-8-[(2s,3r,6s)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)


   

7-[8-(3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

7-[8-(3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)


   

2,18-dimethyl 4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-2,18-dicarboxylate

2,18-dimethyl 4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-2,18-dicarboxylate

C24H30N2O5 (426.2155)


   

2-[(4-methylpentyl)oxy]-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

2-[(4-methylpentyl)oxy]-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C18H34O11 (426.2101)


   

5,5'-diisopropyl-3,3',8,8'-tetramethyl-[2,2'-binaphthalene]-1,1'-diol

5,5'-diisopropyl-3,3',8,8'-tetramethyl-[2,2'-binaphthalene]-1,1'-diol

C30H34O2 (426.2559)


   

(2s,2'r,3s,3ar,4'r,4'as,6r,7ar,8'as)-3,3a-dihydroxy-2-methoxy-2',5',5',8'a-tetramethyl-decahydro-2h,2'h-spiro[furo[2,3-b]pyran-6,1'-naphthalen]-4'-yl acetate

(2s,2'r,3s,3ar,4'r,4'as,6r,7ar,8'as)-3,3a-dihydroxy-2-methoxy-2',5',5',8'a-tetramethyl-decahydro-2h,2'h-spiro[furo[2,3-b]pyran-6,1'-naphthalen]-4'-yl acetate

C23H38O7 (426.2617)


   

(1s,1's,2's,5's,9's,10'r,13'r,14's)-5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione

(1s,1's,2's,5's,9's,10'r,13'r,14's)-5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione

C26H34O5 (426.2406)


   

(1r,2s,3s,5s,6s,8s,9s,10s,11r,15s,16r)-3,9,10,15-tetrahydroxy-16-methoxy-6-(methoxymethyl)-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

(1r,2s,3s,5s,6s,8s,9s,10s,11r,15s,16r)-3,9,10,15-tetrahydroxy-16-methoxy-6-(methoxymethyl)-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

C22H34O8 (426.2254)


   

methyl 11-(acetyloxy)-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate

methyl 11-(acetyloxy)-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate

C24H30N2O5 (426.2155)


   

8-[2-(furan-3-yl)-2-hydroxyethyl]-3,4,5-trihydroxy-4-(hydroxymethyl)-4a,7,8-trimethyl-hexahydro-1h-naphthalen-1-yl acetate

8-[2-(furan-3-yl)-2-hydroxyethyl]-3,4,5-trihydroxy-4-(hydroxymethyl)-4a,7,8-trimethyl-hexahydro-1h-naphthalen-1-yl acetate

C22H34O8 (426.2254)


   

(1s,4s,7s,9r)-16-acetyl-7-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-5-oxa-2,16-diazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione

(1s,4s,7s,9r)-16-acetyl-7-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-5-oxa-2,16-diazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione

C24H30N2O5 (426.2155)


   

7-[8-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

7-[8-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)


   

[(1r,2s,5r,6s,7s,8r,9s,10s,11r,18r)-6,7,9,10,18-pentahydroxy-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-6-yl]methyl acetate

[(1r,2s,5r,6s,7s,8r,9s,10s,11r,18r)-6,7,9,10,18-pentahydroxy-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-6-yl]methyl acetate

C22H34O8 (426.2254)


   

2-{2-[(1-hydroxyethylidene)amino]-n,3-dimethylbutanamido}-n-[(1z)-2-(1h-indol-3-yl)ethenyl]-4-methylpentanimidic acid

2-{2-[(1-hydroxyethylidene)amino]-n,3-dimethylbutanamido}-n-[(1z)-2-(1h-indol-3-yl)ethenyl]-4-methylpentanimidic acid

C24H34N4O3 (426.2631)


   

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(1r,2e,4s,7e)-4-isopropyl-1,7-dimethylcyclodeca-2,7-dien-1-yl]oxy}oxan-2-yl]methyl acetate

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(1r,2e,4s,7e)-4-isopropyl-1,7-dimethylcyclodeca-2,7-dien-1-yl]oxy}oxan-2-yl]methyl acetate

C23H38O7 (426.2617)


   

[(1s,3r,5r,7ar)-7-(hydroxymethyl)-3,5-dimethoxy-1-[(3-methylbutanoyl)oxy]-1h,3h,5h,7ah-cyclopenta[c]pyran-4-yl]methyl 3-methylbutanoate

[(1s,3r,5r,7ar)-7-(hydroxymethyl)-3,5-dimethoxy-1-[(3-methylbutanoyl)oxy]-1h,3h,5h,7ah-cyclopenta[c]pyran-4-yl]methyl 3-methylbutanoate

C22H34O8 (426.2254)


   

(2s,2's,3r,3as,4's,4'ar,6s,7ar,8'ar)-3,3a-dihydroxy-2-methoxy-2',5',5',8'a-tetramethyl-decahydro-2h,2'h-spiro[furo[2,3-b]pyran-6,1'-naphthalen]-4'-yl acetate

(2s,2's,3r,3as,4's,4'ar,6s,7ar,8'ar)-3,3a-dihydroxy-2-methoxy-2',5',5',8'a-tetramethyl-decahydro-2h,2'h-spiro[furo[2,3-b]pyran-6,1'-naphthalen]-4'-yl acetate

C23H38O7 (426.2617)


   

2-(hexyloxy)-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

2-(hexyloxy)-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C18H34O11 (426.2101)


   

asebotoxin i

NA

C23H38O7 (426.2617)


{"Ingredient_id": "HBIN017046","Ingredient_name": "asebotoxin i","Alias": "NA","Ingredient_formula": "C23H38O7","Ingredient_Smile": "CCC(=O)OC1C2CCC3C1(CC(C4(C(C3(C)O)CC(C4(C)C)O)O)O)CC2(C)O","Ingredient_weight": "426.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1848","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "135929163","DrugBank_id": "NA"}

   

(2r,3r,4s,5s,6r)-2-[(4-methylpentyl)oxy]-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-[(4-methylpentyl)oxy]-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C18H34O11 (426.2101)


   

(1s,10r,13r,14r,22s)-15-ethylidene-4,10-dimethoxy-17-methyl-11-oxa-8,17-diazapentacyclo[12.5.2.1¹,⁸.0²,⁷.0¹³,²²]docosa-2,4,6-triene-9,20-dione

(1s,10r,13r,14r,22s)-15-ethylidene-4,10-dimethoxy-17-methyl-11-oxa-8,17-diazapentacyclo[12.5.2.1¹,⁸.0²,⁷.0¹³,²²]docosa-2,4,6-triene-9,20-dione

C24H30N2O5 (426.2155)


   

methyl (13e)-18-[(acetyloxy)methyl]-13-ethylidene-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

methyl (13e)-18-[(acetyloxy)methyl]-13-ethylidene-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C24H30N2O5 (426.2155)


   

3,4,8-trihydroxy-4,8,12-trimethyl-15-methylidene-11,14-dioxo-13-oxabicyclo[10.3.2]heptadecan-7-yl acetate

3,4,8-trihydroxy-4,8,12-trimethyl-15-methylidene-11,14-dioxo-13-oxabicyclo[10.3.2]heptadecan-7-yl acetate

C22H34O8 (426.2254)


   

4,5-dihydroxy-6-(hydroxymethyl)-2-[(4-isopropyl-1,7-dimethylcyclodeca-2,7-dien-1-yl)oxy]oxan-3-yl acetate

4,5-dihydroxy-6-(hydroxymethyl)-2-[(4-isopropyl-1,7-dimethylcyclodeca-2,7-dien-1-yl)oxy]oxan-3-yl acetate

C23H38O7 (426.2617)


   

(1s,10r,13r,14r,15z,22s)-15-ethylidene-4,10-dimethoxy-17-methyl-11-oxa-8,17-diazapentacyclo[12.5.2.1¹,⁸.0²,⁷.0¹³,²²]docosa-2,4,6-triene-9,20-dione

(1s,10r,13r,14r,15z,22s)-15-ethylidene-4,10-dimethoxy-17-methyl-11-oxa-8,17-diazapentacyclo[12.5.2.1¹,⁸.0²,⁷.0¹³,²²]docosa-2,4,6-triene-9,20-dione

C24H30N2O5 (426.2155)


   

methyl (1r,2s,6s,15s,16r)-9-(ethylamino)-11-(2-hydroxyethyl)-2,15-dimethyl-18-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-9,11,13-triene-12-carboxylate

methyl (1r,2s,6s,15s,16r)-9-(ethylamino)-11-(2-hydroxyethyl)-2,15-dimethyl-18-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-9,11,13-triene-12-carboxylate

C25H34N2O4 (426.2518)


   

methyl (1r,9r,10r,11s,12r,13r,19r)-11-(acetyloxy)-12-ethyl-8-methyl-20-oxa-8,16-diazahexacyclo[10.6.1.1¹⁰,¹³.0¹,⁹.0²,⁷.0¹⁶,¹⁹]icosa-2,4,6-triene-10-carboxylate

methyl (1r,9r,10r,11s,12r,13r,19r)-11-(acetyloxy)-12-ethyl-8-methyl-20-oxa-8,16-diazahexacyclo[10.6.1.1¹⁰,¹³.0¹,⁹.0²,⁷.0¹⁶,¹⁹]icosa-2,4,6-triene-10-carboxylate

C24H30N2O5 (426.2155)


   

(6ar)-3,6a-dimethyl-9-[(2s)-2-methyldodecanoyl]furo[2,3-h]isochromene-6,8-dione

(6ar)-3,6a-dimethyl-9-[(2s)-2-methyldodecanoyl]furo[2,3-h]isochromene-6,8-dione

C26H34O5 (426.2406)


   

methyl (3r,4s,5r)-3-(acetyloxy)-4-{[(3r)-3-methylpentanoyl]oxy}-5-{[(3s)-3-methylpentanoyl]oxy}cyclohex-1-ene-1-carboxylate

methyl (3r,4s,5r)-3-(acetyloxy)-4-{[(3r)-3-methylpentanoyl]oxy}-5-{[(3s)-3-methylpentanoyl]oxy}cyclohex-1-ene-1-carboxylate

C22H34O8 (426.2254)


   

(1s,12r,15s,23r)-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetraazahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²²]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione

(1s,12r,15s,23r)-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetraazahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²²]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione

C26H26N4O2 (426.2056)


   

3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate

3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate

C23H38O7 (426.2617)


   

2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol

2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol

C26H34O5 (426.2406)


   

(2r,3s,4s,5r,6r)-3,4,5-trimethoxy-2-(methoxymethyl)-6-{[(2s,3s,4s)-1,3,4,5-tetramethoxypentan-2-yl]oxy}oxane

(2r,3s,4s,5r,6r)-3,4,5-trimethoxy-2-(methoxymethyl)-6-{[(2s,3s,4s)-1,3,4,5-tetramethoxypentan-2-yl]oxy}oxane

C19H38O10 (426.2465)


   

(2s,3r,4s,5s,6r)-3-(acetyloxy)-5-hydroxy-6-methyl-2-({2-[(1r)-4-methylcyclohex-3-en-1-yl]propan-2-yl}oxy)oxan-4-yl (2s)-2-methylbutanoate

(2s,3r,4s,5s,6r)-3-(acetyloxy)-5-hydroxy-6-methyl-2-({2-[(1r)-4-methylcyclohex-3-en-1-yl]propan-2-yl}oxy)oxan-4-yl (2s)-2-methylbutanoate

C23H38O7 (426.2617)


   

(1r,3s,4r,7r,8s,12r)-3,4,8-trihydroxy-4,8,12-trimethyl-15-methylidene-11,14-dioxo-13-oxabicyclo[10.3.2]heptadecan-7-yl acetate

(1r,3s,4r,7r,8s,12r)-3,4,8-trihydroxy-4,8,12-trimethyl-15-methylidene-11,14-dioxo-13-oxabicyclo[10.3.2]heptadecan-7-yl acetate

C22H34O8 (426.2254)


   

(5z,8z,11z,13e,15s,17z)-15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one

(5z,8z,11z,13e,15s,17z)-15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one

C26H34O5 (426.2406)


   

[(1r,2s,5r,6s,7s,8r,9s,10s,11r,18s)-6,7,9,10,18-pentahydroxy-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-6-yl]methyl acetate

[(1r,2s,5r,6s,7s,8r,9s,10s,11r,18s)-6,7,9,10,18-pentahydroxy-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-6-yl]methyl acetate

C22H34O8 (426.2254)


   

(2r,2's,3r,3as,4's,4'ar,6s,7as,8'ar)-3,3a-dihydroxy-2-methoxy-2',5',5',8'a-tetramethyl-decahydro-2h,2'h-spiro[furo[2,3-b]pyran-6,1'-naphthalen]-4'-yl acetate

(2r,2's,3r,3as,4's,4'ar,6s,7as,8'ar)-3,3a-dihydroxy-2-methoxy-2',5',5',8'a-tetramethyl-decahydro-2h,2'h-spiro[furo[2,3-b]pyran-6,1'-naphthalen]-4'-yl acetate

C23H38O7 (426.2617)


   

methyl (13e)-10-(acetyloxy)-13-ethylidene-18-(hydroxymethyl)-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

methyl (13e)-10-(acetyloxy)-13-ethylidene-18-(hydroxymethyl)-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C24H30N2O5 (426.2155)


   

3,3a-dihydroxy-2-methoxy-2',5',5',8'a-tetramethyl-decahydro-2h,2'h-spiro[furo[2,3-b]pyran-6,1'-naphthalen]-4'-yl acetate

3,3a-dihydroxy-2-methoxy-2',5',5',8'a-tetramethyl-decahydro-2h,2'h-spiro[furo[2,3-b]pyran-6,1'-naphthalen]-4'-yl acetate

C23H38O7 (426.2617)


   

3,12,14,17-tetrahydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate

3,12,14,17-tetrahydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate

C22H34O8 (426.2254)


   

(1s,3r,4r,6s,8s,9r,10r,13r,14r,16s)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate

(1s,3r,4r,6s,8s,9r,10r,13r,14r,16s)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate

C23H38O7 (426.2617)


   

(7r)-7-[(1e,3e,5e,7e)-8-[(2s,5s,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(7r)-7-[(1e,3e,5e,7e)-8-[(2s,5s,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)


   

methyl 12-[1-(acetyloxy)ethyl]-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

methyl 12-[1-(acetyloxy)ethyl]-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

C24H30N2O5 (426.2155)


   

(1s,4s,6r,7s)-7-[(1e,3e,5e,7e)-8-[(2s,5s,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(1s,4s,6r,7s)-7-[(1e,3e,5e,7e)-8-[(2s,5s,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)


   

6,8-dimethoxy-7-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]chromen-2-one

6,8-dimethoxy-7-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]chromen-2-one

C26H34O5 (426.2406)


   

7-{6-formyl-2-hydroxy-3-methyl-2-[2-methyl-3-(sec-butyl)oxiran-2-yl]-4a,5,8,8a-tetrahydro-1h-naphthalen-1-yl}hepta-2,4,6-trienoic acid

7-{6-formyl-2-hydroxy-3-methyl-2-[2-methyl-3-(sec-butyl)oxiran-2-yl]-4a,5,8,8a-tetrahydro-1h-naphthalen-1-yl}hepta-2,4,6-trienoic acid

C26H34O5 (426.2406)


   

5-{5-[(2-carboxyacetyl)oxy]-3-methylpentyl}-6-hydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1-carboxylic acid

5-{5-[(2-carboxyacetyl)oxy]-3-methylpentyl}-6-hydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1-carboxylic acid

C23H38O7 (426.2617)


   

15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-3-ene-5,13-dione

15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-3-ene-5,13-dione

C26H34O5 (426.2406)


   

n-[4-(5-chloro-2,6,6-trimethyloxan-2-yl)-6-hydroxy-5-isocyanato-1,6-dimethyl-octahydronaphthalen-1-yl]carboximidic acid

n-[4-(5-chloro-2,6,6-trimethyloxan-2-yl)-6-hydroxy-5-isocyanato-1,6-dimethyl-octahydronaphthalen-1-yl]carboximidic acid

C22H35ClN2O4 (426.2285)


   

(4s,6r)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(4s,6r)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)


   

(1s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate

(1s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate

C23H38O7 (426.2617)


   

{3,4,5-trihydroxy-6-[(4-isopropyl-1,7-dimethylcyclodeca-2,7-dien-1-yl)oxy]oxan-2-yl}methyl acetate

{3,4,5-trihydroxy-6-[(4-isopropyl-1,7-dimethylcyclodeca-2,7-dien-1-yl)oxy]oxan-2-yl}methyl acetate

C23H38O7 (426.2617)


   

(1s,2r,5r,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl 3-phenylprop-2-enoate

(1s,2r,5r,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl 3-phenylprop-2-enoate

C26H34O5 (426.2406)


   

(7r)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(7r)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)


   

(1r,1's,2's,5's,9's,10'r,13'r,14's)-5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione

(1r,1's,2's,5's,9's,10'r,13'r,14's)-5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione

C26H34O5 (426.2406)


   

2,18-dimethyl (1s,9r,16s,18r,21s)-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-2,18-dicarboxylate

2,18-dimethyl (1s,9r,16s,18r,21s)-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-2,18-dicarboxylate

C24H30N2O5 (426.2155)


   

(13z,21r)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol

(13z,21r)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol

C26H34O5 (426.2406)


   

(4s,6r)-7-[(1e,3e,5e)-6-[(2s,3r,3ar,4s,6ar)-3-hydroxy-2,3,5,6a-tetramethyl-2h,3ah,4h-cyclopenta[b]furan-4-yl]hexa-1,3,5-trien-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(4s,6r)-7-[(1e,3e,5e)-6-[(2s,3r,3ar,4s,6ar)-3-hydroxy-2,3,5,6a-tetramethyl-2h,3ah,4h-cyclopenta[b]furan-4-yl]hexa-1,3,5-trien-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)


   

methyl 11-(acetyloxy)-12-ethyl-8-methyl-20-oxa-8,16-diazahexacyclo[10.6.1.1¹⁰,¹³.0¹,⁹.0²,⁷.0¹⁶,¹⁹]icosa-2,4,6-triene-10-carboxylate

methyl 11-(acetyloxy)-12-ethyl-8-methyl-20-oxa-8,16-diazahexacyclo[10.6.1.1¹⁰,¹³.0¹,⁹.0²,⁷.0¹⁶,¹⁹]icosa-2,4,6-triene-10-carboxylate

C24H30N2O5 (426.2155)


   

2-{[(1s,2s,5s,6s,7r,10r,11s)-5-hydroxy-5,7,11-trimethyl-12-oxo-13-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadecan-6-yl]methyl}cyclohexa-2,5-diene-1,4-dione

2-{[(1s,2s,5s,6s,7r,10r,11s)-5-hydroxy-5,7,11-trimethyl-12-oxo-13-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadecan-6-yl]methyl}cyclohexa-2,5-diene-1,4-dione

C26H34O5 (426.2406)


   

3-[(1s,2s,3s)-2,3-dimethyl-2-{[(2-oxochromen-7-yl)oxy]methyl}-6-(propan-2-ylidene)cyclohexyl]propyl acetate

3-[(1s,2s,3s)-2,3-dimethyl-2-{[(2-oxochromen-7-yl)oxy]methyl}-6-(propan-2-ylidene)cyclohexyl]propyl acetate

C26H34O5 (426.2406)


   

n-[(1s,4s,4as,5r,6r,8as)-4-[(2r,5s)-5-chloro-2,6,6-trimethyloxan-2-yl]-6-hydroxy-5-isocyanato-1,6-dimethyl-octahydronaphthalen-1-yl]carboximidic acid

n-[(1s,4s,4as,5r,6r,8as)-4-[(2r,5s)-5-chloro-2,6,6-trimethyloxan-2-yl]-6-hydroxy-5-isocyanato-1,6-dimethyl-octahydronaphthalen-1-yl]carboximidic acid

C22H35ClN2O4 (426.2285)


   

3,9,10,15-tetrahydroxy-16-methoxy-6-(methoxymethyl)-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

3,9,10,15-tetrahydroxy-16-methoxy-6-(methoxymethyl)-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

C22H34O8 (426.2254)


   

(1s,13r,14s,17s,19s)-10-hydroxy-7-imino-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),9-trien-19-yl acetate

(1s,13r,14s,17s,19s)-10-hydroxy-7-imino-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),9-trien-19-yl acetate

C25H34N2O4 (426.2518)


   

2-{2-[(1-hydroxyethylidene)amino]-n,3-dimethylbutanamido}-n-[2-(1h-indol-3-yl)ethenyl]-4-methylpentanimidic acid

2-{2-[(1-hydroxyethylidene)amino]-n,3-dimethylbutanamido}-n-[2-(1h-indol-3-yl)ethenyl]-4-methylpentanimidic acid

C24H34N4O3 (426.2631)


   

(13e,21r)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol

(13e,21r)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol

C26H34O5 (426.2406)


   

[(1s,3s,5r,7ar)-7-(hydroxymethyl)-3,5-dimethoxy-1-[(3-methylbutanoyl)oxy]-1h,3h,5h,7ah-cyclopenta[c]pyran-4-yl]methyl 3-methylbutanoate

[(1s,3s,5r,7ar)-7-(hydroxymethyl)-3,5-dimethoxy-1-[(3-methylbutanoyl)oxy]-1h,3h,5h,7ah-cyclopenta[c]pyran-4-yl]methyl 3-methylbutanoate

C22H34O8 (426.2254)


   

(1r,2r,3s,6s,7r,9s,10s,11s,13r,14r)-6,9,11,13,14-pentahydroxy-11-isopropyl-3,7,10-trimethyl-15-oxapentacyclo[7.5.1.0¹,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecan-2-yl acetate

(1r,2r,3s,6s,7r,9s,10s,11s,13r,14r)-6,9,11,13,14-pentahydroxy-11-isopropyl-3,7,10-trimethyl-15-oxapentacyclo[7.5.1.0¹,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecan-2-yl acetate

C22H34O8 (426.2254)


   

(1r,3s,4r,4as,5s,7r,8s,8ar)-8-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-3,4,5-trihydroxy-4-(hydroxymethyl)-4a,7,8-trimethyl-hexahydro-1h-naphthalen-1-yl acetate

(1r,3s,4r,4as,5s,7r,8s,8ar)-8-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-3,4,5-trihydroxy-4-(hydroxymethyl)-4a,7,8-trimethyl-hexahydro-1h-naphthalen-1-yl acetate

C22H34O8 (426.2254)


   

3,4,5-trimethoxy-2-(methoxymethyl)-6-[(1,3,4,5-tetramethoxypentan-2-yl)oxy]oxane

3,4,5-trimethoxy-2-(methoxymethyl)-6-[(1,3,4,5-tetramethoxypentan-2-yl)oxy]oxane

C19H38O10 (426.2465)


   

(1r,2s,3r,4s,7r,8z,12s,13r,14r,17r)-3,12,14,17-tetrahydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate

(1r,2s,3r,4s,7r,8z,12s,13r,14r,17r)-3,12,14,17-tetrahydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate

C22H34O8 (426.2254)


   

(1s,2s,3s,5s,6r,8r,9s,10s,11r,16s,18r)-3,9,10,18-tetrahydroxy-16-methoxy-6-(methoxymethyl)-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

(1s,2s,3s,5s,6r,8r,9s,10s,11r,16s,18r)-3,9,10,18-tetrahydroxy-16-methoxy-6-(methoxymethyl)-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

C22H34O8 (426.2254)


   

methyl (1r,9r,10s,12r,19r)-11-(acetyloxy)-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate

methyl (1r,9r,10s,12r,19r)-11-(acetyloxy)-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate

C24H30N2O5 (426.2155)


   

10-hydroxy-7-imino-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),9-trien-19-yl acetate

10-hydroxy-7-imino-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),9-trien-19-yl acetate

C25H34N2O4 (426.2518)


   

methyl (1s,15r,18s,19s,20r)-18-(acetyloxy)-6-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate

methyl (1s,15r,18s,19s,20r)-18-(acetyloxy)-6-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate

C24H30N2O5 (426.2155)


   

(4s,6r)-7-[(1e,3e,5e)-6-[(2s,3s,3as,4r,6as)-3-hydroxy-2,3,5,6a-tetramethyl-2h,3ah,4h-cyclopenta[b]furan-4-yl]hexa-1,3,5-trien-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(4s,6r)-7-[(1e,3e,5e)-6-[(2s,3s,3as,4r,6as)-3-hydroxy-2,3,5,6a-tetramethyl-2h,3ah,4h-cyclopenta[b]furan-4-yl]hexa-1,3,5-trien-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)


   

methyl (1r,12r,19r)-12-[(1s)-1-(acetyloxy)ethyl]-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

methyl (1r,12r,19r)-12-[(1s)-1-(acetyloxy)ethyl]-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

C24H30N2O5 (426.2155)


   

3,6a-dimethyl-9-(2-methyldodecanoyl)furo[2,3-h]isochromene-6,8-dione

3,6a-dimethyl-9-(2-methyldodecanoyl)furo[2,3-h]isochromene-6,8-dione

C26H34O5 (426.2406)


   

methyl (1s,9s,10r,12s,13e,18r)-10-(acetyloxy)-13-ethylidene-18-(hydroxymethyl)-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

methyl (1s,9s,10r,12s,13e,18r)-10-(acetyloxy)-13-ethylidene-18-(hydroxymethyl)-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C24H30N2O5 (426.2155)


   

2-[(6-hydroxy-5,7-dimethyl-3-pentyl-3,4-dihydro-1h-2-benzopyran-8-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(6-hydroxy-5,7-dimethyl-3-pentyl-3,4-dihydro-1h-2-benzopyran-8-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H34O8 (426.2254)


   

(2r,3r,4s,5r,6s)-5-(acetyloxy)-4-hydroxy-2-methyl-6-({2-[(1r)-4-methylcyclohex-3-en-1-yl]propan-2-yl}oxy)oxan-3-yl (2s)-2-methylbutanoate

(2r,3r,4s,5r,6s)-5-(acetyloxy)-4-hydroxy-2-methyl-6-({2-[(1r)-4-methylcyclohex-3-en-1-yl]propan-2-yl}oxy)oxan-3-yl (2s)-2-methylbutanoate

C23H38O7 (426.2617)


   

8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl 4-hydroxyoct-2-enoate

8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl 4-hydroxyoct-2-enoate

C22H34O8 (426.2254)


   

(2s,3r,4s,5s,6r)-2-{[(3s)-6-hydroxy-5,7-dimethyl-3-pentyl-3,4-dihydro-1h-2-benzopyran-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3s)-6-hydroxy-5,7-dimethyl-3-pentyl-3,4-dihydro-1h-2-benzopyran-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C22H34O8 (426.2254)


   

(4s,6r)-7-[(1e,3e,5e,7e)-8-[(2s,3r,6r)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(4s,6r)-7-[(1e,3e,5e,7e)-8-[(2s,3r,6r)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)


   

methyl (1r,9r,10r,11s,12r,19r)-11-(acetyloxy)-12-ethyl-8-methyl-20-oxa-8,16-diazahexacyclo[10.6.1.1¹⁰,¹³.0¹,⁹.0²,⁷.0¹⁶,¹⁹]icosa-2,4,6-triene-10-carboxylate

methyl (1r,9r,10r,11s,12r,19r)-11-(acetyloxy)-12-ethyl-8-methyl-20-oxa-8,16-diazahexacyclo[10.6.1.1¹⁰,¹³.0¹,⁹.0²,⁷.0¹⁶,¹⁹]icosa-2,4,6-triene-10-carboxylate

C24H30N2O5 (426.2155)


   

15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one

15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one

C26H34O5 (426.2406)


   

(2s,3r,4r,4as,7r,8s,8as)-8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl (2e,4s)-4-hydroxyoct-2-enoate

(2s,3r,4r,4as,7r,8s,8as)-8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl (2e,4s)-4-hydroxyoct-2-enoate

C22H34O8 (426.2254)


   

(1r,2s,3s,5s,6s,8s,9s,10s,11r,15s,16s)-3,9,10,15-tetrahydroxy-16-methoxy-6-(methoxymethyl)-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

(1r,2s,3s,5s,6s,8s,9s,10s,11r,15s,16s)-3,9,10,15-tetrahydroxy-16-methoxy-6-(methoxymethyl)-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

C22H34O8 (426.2254)


   

methyl 11-(acetyloxy)-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-3-carboxylate

methyl 11-(acetyloxy)-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-3-carboxylate

C24H30N2O5 (426.2155)


   

(1s,3r,4r,6s,8s,9r,10r,13r,14r)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate

(1s,3r,4r,6s,8s,9r,10r,13r,14r)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate

C23H38O7 (426.2617)


   

(1s,3r,4s,7s,8r,12s)-3,4,8-trihydroxy-4,8,12-trimethyl-15-methylidene-11,14-dioxo-13-oxabicyclo[10.3.2]heptadecan-7-yl acetate

(1s,3r,4s,7s,8r,12s)-3,4,8-trihydroxy-4,8,12-trimethyl-15-methylidene-11,14-dioxo-13-oxabicyclo[10.3.2]heptadecan-7-yl acetate

C22H34O8 (426.2254)


   

6,8-dimethoxy-7-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}chromen-2-one

6,8-dimethoxy-7-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}chromen-2-one

C26H34O5 (426.2406)


   

(1s,3s,4r,6s,8s,9r,10r,13r,14r)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate

(1s,3s,4r,6s,8s,9r,10r,13r,14r)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate

C23H38O7 (426.2617)


   

(1s,4ar,5s,6s,8as)-5-[(3s)-5-[(2-carboxyacetyl)oxy]-3-methylpentyl]-6-hydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1-carboxylic acid

(1s,4ar,5s,6s,8as)-5-[(3s)-5-[(2-carboxyacetyl)oxy]-3-methylpentyl]-6-hydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1-carboxylic acid

C23H38O7 (426.2617)


   

(2s,3r,4s,5s,6r)-2-{[(2r,3r,4s,5s,6r)-2-(hexyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2r,3r,4s,5s,6r)-2-(hexyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C18H34O11 (426.2101)


   

{6,7,9,10,15-pentahydroxy-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-6-yl}methyl acetate

{6,7,9,10,15-pentahydroxy-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-6-yl}methyl acetate

C22H34O8 (426.2254)


   

(2r,3r,4s,5s,6r)-2-(hexyloxy)-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-(hexyloxy)-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C18H34O11 (426.2101)


   

2-{[2-(hexyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[2-(hexyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C18H34O11 (426.2101)


   

[(1s,2s,5r,6s,7s,8s,9s,10s,11r,15s)-6,7,9,10,15-pentahydroxy-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-6-yl]methyl acetate

[(1s,2s,5r,6s,7s,8s,9s,10s,11r,15s)-6,7,9,10,15-pentahydroxy-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-6-yl]methyl acetate

C22H34O8 (426.2254)


   

(2r,3s)-2-{[(1s,4ar,5r,8as)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-3-(methoxycarbonyl)pentanedioic acid

(2r,3s)-2-{[(1s,4ar,5r,8as)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-3-(methoxycarbonyl)pentanedioic acid

C22H34O8 (426.2254)


   

(1r,2s,3r,4r,6r,8s,9s,10r,11r,14r,15r,17r)-2,4,10,15,17-pentahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-3-yl acetate

(1r,2s,3r,4r,6r,8s,9s,10r,11r,14r,15r,17r)-2,4,10,15,17-pentahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-3-yl acetate

C22H34O8 (426.2254)


   

5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione

5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione

C26H34O5 (426.2406)


   

16-acetyl-7-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-5-oxa-2,16-diazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione

16-acetyl-7-hydroxy-9-(2-methylbut-3-en-2-yl)-4-(2-methylpropyl)-5-oxa-2,16-diazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione

C24H30N2O5 (426.2155)


   

(2r,2'r,3s,3ar,4'r,4'as,6r,7as,8'as)-3,3a-dihydroxy-2-methoxy-2',5',5',8'a-tetramethyl-decahydro-2h,2'h-spiro[furo[2,3-b]pyran-6,1'-naphthalen]-4'-yl acetate

(2r,2'r,3s,3ar,4'r,4'as,6r,7as,8'as)-3,3a-dihydroxy-2-methoxy-2',5',5',8'a-tetramethyl-decahydro-2h,2'h-spiro[furo[2,3-b]pyran-6,1'-naphthalen]-4'-yl acetate

C23H38O7 (426.2617)


   

(1s,2r,5r,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl (2e)-3-phenylprop-2-enoate

(1s,2r,5r,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl (2e)-3-phenylprop-2-enoate

C26H34O5 (426.2406)


   

(2e,4e,6e)-7-[(1s,2r,4ar,8ar)-2-[(2s,3r)-3-[(2r)-butan-2-yl]-2-methyloxiran-2-yl]-6-formyl-2-hydroxy-3-methyl-4a,5,8,8a-tetrahydro-1h-naphthalen-1-yl]hepta-2,4,6-trienoic acid

(2e,4e,6e)-7-[(1s,2r,4ar,8ar)-2-[(2s,3r)-3-[(2r)-butan-2-yl]-2-methyloxiran-2-yl]-6-formyl-2-hydroxy-3-methyl-4a,5,8,8a-tetrahydro-1h-naphthalen-1-yl]hepta-2,4,6-trienoic acid

C26H34O5 (426.2406)


   

(1s,2r,3s,4r,7s,8z,12r,13s,14s,17s)-3,12,14,17-tetrahydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate

(1s,2r,3s,4r,7s,8z,12r,13s,14s,17s)-3,12,14,17-tetrahydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate

C22H34O8 (426.2254)


   

methyl (1r,9s,10s,11r,12r,19r)-11-(acetyloxy)-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate

methyl (1r,9s,10s,11r,12r,19r)-11-(acetyloxy)-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate

C24H30N2O5 (426.2155)


   

(5z,8z,11z,13e,17z)-15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one

(5z,8z,11z,13e,17z)-15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one

C26H34O5 (426.2406)


   

{6,7,9,10,18-pentahydroxy-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-6-yl}methyl acetate

{6,7,9,10,18-pentahydroxy-12,12-dimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-6-yl}methyl acetate

C22H34O8 (426.2254)


   

methyl 3-(acetyloxy)-4,5-bis[(3-methylpentanoyl)oxy]cyclohex-1-ene-1-carboxylate

methyl 3-(acetyloxy)-4,5-bis[(3-methylpentanoyl)oxy]cyclohex-1-ene-1-carboxylate

C22H34O8 (426.2254)


   

2,18-dimethyl (1r,9r,16r,18r,21s)-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-2,18-dicarboxylate

2,18-dimethyl (1r,9r,16r,18r,21s)-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-2,18-dicarboxylate

C24H30N2O5 (426.2155)


   

5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl 3-phenylprop-2-enoate

5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl 3-phenylprop-2-enoate

C26H34O5 (426.2406)


   

(2s,3r,4r,4as,7s,8s,8as)-8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl (2e,4s)-4-hydroxyoct-2-enoate

(2s,3r,4r,4as,7s,8s,8as)-8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl (2e,4s)-4-hydroxyoct-2-enoate

C22H34O8 (426.2254)


   

(1s,4s,6r,7s)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

(1s,4s,6r,7s)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C26H34O5 (426.2406)